-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Lyra Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2024.
- Lyra Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$48.1M, a 208% decline year-over-year.
- Lyra Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$101M, a 66.6% decline year-over-year.
- Lyra Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$62.7M, a 13.4% decline from 2022.
- Lyra Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$55.3M, a 27% decline from 2021.
- Lyra Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$43.5M, a 96.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)